ResearcherZhengzhou UniversityActive in the last 2 years

Bowen Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1759-9729; OpenAlex author ID A5087639740. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. Co-author DOI 10.1038/s41467-024-54963-y ↗
Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies. First author DOI 10.1016/j.canlet.2023.216138 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yiye Li · 2 shared papers, 2023–2024 · strength 0.43
- Paper Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies. DOI 10.1016/j.canlet.2023.216138 ↗
- Paper Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. DOI 10.1038/s41467-024-54963-y ↗
Zhiqin Wang · 2 shared papers, 2023–2024 · strength 0.43
- Paper Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies. DOI 10.1016/j.canlet.2023.216138 ↗
- Paper Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. DOI 10.1038/s41467-024-54963-y ↗
Guangjun Nie · 2 shared papers, 2023–2024 · strength 0.43
- Paper Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies. DOI 10.1016/j.canlet.2023.216138 ↗
- Paper Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. DOI 10.1038/s41467-024-54963-y ↗
Xudong Wang · 1 shared paper, 2024 · strength 0.20
- Paper Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine. DOI 10.1038/s41467-024-54963-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.